Orthox was founded in 2008 by Dr Nick Skaer and Professor Oliver Kessler to exploit the potential of silk technology developed by Professor Fritz Vollrath’s Silk Group at the University of Oxford.
The Company is developing tissue regenerative knee implants to help patients return to a fully active, pain free life. Orthox’s FibroFix™ technology is based on fibroin protein, which is derived from the silk moth, Bombyx mori. The Company is developing FibroFix™ Cartilage for repairing the articular cartilage, and FibroFix™ Meniscus for replacing the meniscal cartilage, both in the knee. The material’s high tensile strength, flexibility and biocompatibility make it a good choice for this high growth market, where the alternative is full knee replacement surgery.